Alexa

Experts: Lack of remorse could bite 'Pharma Bro'

Martin Shkreli talks with reporters after leaving federal court in New York, Friday, Aug. 4, 2017. Shkreli, the eccentric former pharmaceutical CEO no...
Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securit...
Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securit...
Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securit...
Martin Shkreli, center, leaves federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he...
Martin Shkreli, center, leaves federal court in New York, Friday, Aug. 4, 2017. Shkreli, the eccentric former pharmaceutical CEO notorious for a price...
Martin Shkreli talks with reporters after leaving federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on...
Martin Shkreli, left, talks with reporters while standing next to his attorney Benjamin Brafman after leaving federal court in New York, Friday, Aug. ...
Martin Shkreli, left, and his attorney Benjamin Brafman leave federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been ...
Martin Shkreli, center, stops with his attorneys to talk to reporters in front of federal court in New York, Friday, Aug. 4, 2017. The former pharmace...

Martin Shkreli talks with reporters after leaving federal court in New York, Friday, Aug. 4, 2017. Shkreli, the eccentric former pharmaceutical CEO no...

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securit...

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securit...

Martin Shkreli arrives at federal court in New York, Friday, Aug. 4, 2017. Jurors are starting their fifth day of deliberations at the federal securit...

Martin Shkreli, center, leaves federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on federal charges he...

Martin Shkreli, center, leaves federal court in New York, Friday, Aug. 4, 2017. Shkreli, the eccentric former pharmaceutical CEO notorious for a price...

Martin Shkreli talks with reporters after leaving federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been convicted on...

Martin Shkreli, left, talks with reporters while standing next to his attorney Benjamin Brafman after leaving federal court in New York, Friday, Aug. ...

Martin Shkreli, left, and his attorney Benjamin Brafman leave federal court in New York, Friday, Aug. 4, 2017. The former pharmaceutical CEO has been ...

Martin Shkreli, center, stops with his attorneys to talk to reporters in front of federal court in New York, Friday, Aug. 4, 2017. The former pharmace...

NEW YORK (AP) — A securities fraud conviction has done nothing to quiet Martin Shkreli and experts say that could hurt the so-called "Pharma Bro" at sentencing.

A jury found the former pharmaceutical CEO guilty Friday of deceiving investors in two failed hedge funds he ran.

Afterward, Shkreli's lawyer acknowledged that his client needs to break his habit of trashing critics on social. But within an hour, his client was live-streaming himself as he drank a beer and bragged about his wealth.

Former federal prosecutors say judges can factor in lack of remorse when they sentence people. They say Shkreli's antics would be hard to ignore.

The 34-year-old defendant faces up to 20 years in prison for his conviction on the most serious counts, though the term could be much lower under sentencing guidelines. No date was set.


Updated : 2021-03-05 02:52 GMT+08:00